Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1961 1
1963 3
1965 2
1966 2
1967 4
1969 2
1970 3
1971 5
1973 4
1974 8
1975 3
1976 7
1977 6
1978 10
1979 8
1980 11
1981 13
1982 16
1983 10
1984 11
1985 14
1986 10
1987 21
1988 14
1989 17
1990 18
1991 13
1992 15
1993 19
1994 21
1995 18
1996 21
1997 31
1998 29
1999 23
2000 24
2001 23
2002 25
2003 19
2004 16
2005 26
2006 21
2007 21
2008 23
2009 22
2010 20
2011 20
2012 21
2013 20
2014 25
2015 26
2016 34
2017 30
2018 29
2019 23
2020 28
2021 12
Text availability
Article attribute
Article type
Publication date

Search Results

876 results
Results by year
Filters applied: . Clear all
Page 1
Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.
Koga T, Kobayashi Y, Tomizawa K, Suda K, Kosaka T, Sesumi Y, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Suzuki M, Jänne PA, Mitsudomi T. Koga T, et al. Among authors: chiba m. Lung Cancer. 2018 Dec;126:72-79. doi: 10.1016/j.lungcan.2018.10.019. Epub 2018 Oct 17. Lung Cancer. 2018. PMID: 30527195
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib.
Kobayashi Y, Fujino T, Nishino M, Koga T, Chiba M, Sesumi Y, Ohara S, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T. Kobayashi Y, et al. Among authors: chiba m. J Thorac Oncol. 2018 May;13(5):727-731. doi: 10.1016/j.jtho.2018.01.009. Epub 2018 Feb 2. J Thorac Oncol. 2018. PMID: 29410323 Free article.
876 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page